Peanut Allergy Therapeutics Industry Research Report 2025

Summary

Peanuts are one of the food allergens most commonly associated with anaphylaxis, a sudden and potentially deadly condition that requires immediate attention and treatment.

According to APO Research, The global Peanut Allergy Therapeutics market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Peanut Allergy Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Peanut Allergy Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Peanut Allergy Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Peanut Allergy Therapeutics include Mylan, Bayer, UCB Pharma, J & J, Perrigo, GSK, Kaleo, Amneal Pharma and ALK Abello, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Peanut Allergy Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peanut Allergy Therapeutics.
The Peanut Allergy Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peanut Allergy Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Peanut Allergy Therapeutics Segment by Company

Mylan
Bayer
UCB Pharma
J & J
Perrigo
GSK
Kaleo
Amneal Pharma
ALK Abello
Aimmune Therapeutics
HUAPONT Pharm
Allergy Therapeutics
ASIT Biotech
Sanofi
DBV Technologies
HAL Allergy
Intrommune Therapeutics
Peanut Allergy Therapeutics Segment by Type

Epinephrine Injection
Antihistamines
Oral Immunotherapy
Other
Peanut Allergy Therapeutics Segment by Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Other
Peanut Allergy Therapeutics Segment by Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Other
Peanut Allergy Therapeutics Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peanut Allergy Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peanut Allergy Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peanut Allergy Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Peanut Allergy Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Peanut Allergy Therapeutics by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 Epinephrine Injection
2.2.3 Antihistamines
2.2.4 Oral Immunotherapy
2.2.5 Other
2.3 Peanut Allergy Therapeutics by Distribution Channel
2.3.1 Market Value Comparison by Distribution Channel (2020 VS 2024 VS 2031)
2.3.2 Hospital Pharmacy
2.3.3 Retail Pharmacy
2.3.4 Other
2.4 Assumptions and Limitations
3 Peanut Allergy Therapeutics Breakdown Data by Type
3.1 Global Peanut Allergy Therapeutics Historic Market Size by Type (2020-2025)
3.2 Global Peanut Allergy Therapeutics Forecasted Market Size by Type (2026-2031)
4 Peanut Allergy Therapeutics Breakdown Data by Distribution Channel
4.1 Global Peanut Allergy Therapeutics Historic Market Size by Distribution Channel (2020-2025)
4.2 Global Peanut Allergy Therapeutics Forecasted Market Size by Distribution Channel (2026-2031)
5 Global Growth Trends
5.1 Global Peanut Allergy Therapeutics Market Perspective (2020-2031)
5.2 Global Peanut Allergy Therapeutics Growth Trends by Region
5.2.1 Global Peanut Allergy Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Peanut Allergy Therapeutics Historic Market Size by Region (2020-2025)
5.2.3 Peanut Allergy Therapeutics Forecasted Market Size by Region (2026-2031)
5.3 Peanut Allergy Therapeutics Market Dynamics
5.3.1 Peanut Allergy Therapeutics Industry Trends
5.3.2 Peanut Allergy Therapeutics Market Drivers
5.3.3 Peanut Allergy Therapeutics Market Challenges
5.3.4 Peanut Allergy Therapeutics Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Peanut Allergy Therapeutics Players by Revenue
6.1.1 Global Top Peanut Allergy Therapeutics Players by Revenue (2020-2025)
6.1.2 Global Peanut Allergy Therapeutics Revenue Market Share by Players (2020-2025)
6.2 Global Peanut Allergy Therapeutics Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Peanut Allergy Therapeutics Head Office and Area Served
6.4 Global Peanut Allergy Therapeutics Players, Product Type & Application
6.5 Global Peanut Allergy Therapeutics Manufacturers Established Date
6.6 Global Peanut Allergy Therapeutics Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Peanut Allergy Therapeutics Market Size (2020-2031)
7.2 North America Peanut Allergy Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Peanut Allergy Therapeutics Market Size by Country (2020-2025)
7.4 North America Peanut Allergy Therapeutics Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Peanut Allergy Therapeutics Market Size (2020-2031)
8.2 Europe Peanut Allergy Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Peanut Allergy Therapeutics Market Size by Country (2020-2025)
8.4 Europe Peanut Allergy Therapeutics Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Peanut Allergy Therapeutics Market Size (2020-2031)
9.2 Asia-Pacific Peanut Allergy Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Peanut Allergy Therapeutics Market Size by Country (2020-2025)
9.4 Asia-Pacific Peanut Allergy Therapeutics Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Peanut Allergy Therapeutics Market Size (2020-2031)
10.2 South America Peanut Allergy Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Peanut Allergy Therapeutics Market Size by Country (2020-2025)
10.4 South America Peanut Allergy Therapeutics Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Peanut Allergy Therapeutics Market Size (2020-2031)
11.2 Middle East & Africa Peanut Allergy Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Peanut Allergy Therapeutics Market Size by Country (2020-2025)
11.4 Middle East & Africa Peanut Allergy Therapeutics Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Mylan
12.1.1 Mylan Company Information
12.1.2 Mylan Business Overview
12.1.3 Mylan Revenue in Peanut Allergy Therapeutics Business (2020-2025)
12.1.4 Mylan Peanut Allergy Therapeutics Product Portfolio
12.1.5 Mylan Recent Developments
12.2 Bayer
12.2.1 Bayer Company Information
12.2.2 Bayer Business Overview
12.2.3 Bayer Revenue in Peanut Allergy Therapeutics Business (2020-2025)
12.2.4 Bayer Peanut Allergy Therapeutics Product Portfolio
12.2.5 Bayer Recent Developments
12.3 UCB Pharma
12.3.1 UCB Pharma Company Information
12.3.2 UCB Pharma Business Overview
12.3.3 UCB Pharma Revenue in Peanut Allergy Therapeutics Business (2020-2025)
12.3.4 UCB Pharma Peanut Allergy Therapeutics Product Portfolio
12.3.5 UCB Pharma Recent Developments
12.4 J & J
12.4.1 J & J Company Information
12.4.2 J & J Business Overview
12.4.3 J & J Revenue in Peanut Allergy Therapeutics Business (2020-2025)
12.4.4 J & J Peanut Allergy Therapeutics Product Portfolio
12.4.5 J & J Recent Developments
12.5 Perrigo
12.5.1 Perrigo Company Information
12.5.2 Perrigo Business Overview
12.5.3 Perrigo Revenue in Peanut Allergy Therapeutics Business (2020-2025)
12.5.4 Perrigo Peanut Allergy Therapeutics Product Portfolio
12.5.5 Perrigo Recent Developments
12.6 GSK
12.6.1 GSK Company Information
12.6.2 GSK Business Overview
12.6.3 GSK Revenue in Peanut Allergy Therapeutics Business (2020-2025)
12.6.4 GSK Peanut Allergy Therapeutics Product Portfolio
12.6.5 GSK Recent Developments
12.7 Kaleo
12.7.1 Kaleo Company Information
12.7.2 Kaleo Business Overview
12.7.3 Kaleo Revenue in Peanut Allergy Therapeutics Business (2020-2025)
12.7.4 Kaleo Peanut Allergy Therapeutics Product Portfolio
12.7.5 Kaleo Recent Developments
12.8 Amneal Pharma
12.8.1 Amneal Pharma Company Information
12.8.2 Amneal Pharma Business Overview
12.8.3 Amneal Pharma Revenue in Peanut Allergy Therapeutics Business (2020-2025)
12.8.4 Amneal Pharma Peanut Allergy Therapeutics Product Portfolio
12.8.5 Amneal Pharma Recent Developments
12.9 ALK Abello
12.9.1 ALK Abello Company Information
12.9.2 ALK Abello Business Overview
12.9.3 ALK Abello Revenue in Peanut Allergy Therapeutics Business (2020-2025)
12.9.4 ALK Abello Peanut Allergy Therapeutics Product Portfolio
12.9.5 ALK Abello Recent Developments
12.10 Aimmune Therapeutics
12.10.1 Aimmune Therapeutics Company Information
12.10.2 Aimmune Therapeutics Business Overview
12.10.3 Aimmune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2020-2025)
12.10.4 Aimmune Therapeutics Peanut Allergy Therapeutics Product Portfolio
12.10.5 Aimmune Therapeutics Recent Developments
12.11 HUAPONT Pharm
12.11.1 HUAPONT Pharm Company Information
12.11.2 HUAPONT Pharm Business Overview
12.11.3 HUAPONT Pharm Revenue in Peanut Allergy Therapeutics Business (2020-2025)
12.11.4 HUAPONT Pharm Peanut Allergy Therapeutics Product Portfolio
12.11.5 HUAPONT Pharm Recent Developments
12.12 Allergy Therapeutics
12.12.1 Allergy Therapeutics Company Information
12.12.2 Allergy Therapeutics Business Overview
12.12.3 Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2020-2025)
12.12.4 Allergy Therapeutics Peanut Allergy Therapeutics Product Portfolio
12.12.5 Allergy Therapeutics Recent Developments
12.13 ASIT Biotech
12.13.1 ASIT Biotech Company Information
12.13.2 ASIT Biotech Business Overview
12.13.3 ASIT Biotech Revenue in Peanut Allergy Therapeutics Business (2020-2025)
12.13.4 ASIT Biotech Peanut Allergy Therapeutics Product Portfolio
12.13.5 ASIT Biotech Recent Developments
12.14 Sanofi
12.14.1 Sanofi Company Information
12.14.2 Sanofi Business Overview
12.14.3 Sanofi Revenue in Peanut Allergy Therapeutics Business (2020-2025)
12.14.4 Sanofi Peanut Allergy Therapeutics Product Portfolio
12.14.5 Sanofi Recent Developments
12.15 DBV Technologies
12.15.1 DBV Technologies Company Information
12.15.2 DBV Technologies Business Overview
12.15.3 DBV Technologies Revenue in Peanut Allergy Therapeutics Business (2020-2025)
12.15.4 DBV Technologies Peanut Allergy Therapeutics Product Portfolio
12.15.5 DBV Technologies Recent Developments
12.16 HAL Allergy
12.16.1 HAL Allergy Company Information
12.16.2 HAL Allergy Business Overview
12.16.3 HAL Allergy Revenue in Peanut Allergy Therapeutics Business (2020-2025)
12.16.4 HAL Allergy Peanut Allergy Therapeutics Product Portfolio
12.16.5 HAL Allergy Recent Developments
12.17 Intrommune Therapeutics
12.17.1 Intrommune Therapeutics Company Information
12.17.2 Intrommune Therapeutics Business Overview
12.17.3 Intrommune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2020-2025)
12.17.4 Intrommune Therapeutics Peanut Allergy Therapeutics Product Portfolio
12.17.5 Intrommune Therapeutics Recent Developments
13 Report Conclusion
14 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings